Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Ac R"'
Autor:
Karjala, Geoff, Leswick, David, Anderson, Troy, Toews, Lori, Chatterson, Leslie, Lee, Chel Hee, Lim, Hyun J.
Publikováno v:
In Journal of Medical Imaging and Radiation Sciences September 2017 48(3):254-258
Autor:
Ac, R
Currently, in Australia and overseas, the term social inclusion‚ÄövÑvp is widely used within social policy to inform thinking and practice as a means to reduce inequalities. In the area of education policy, a key goal is to strengthen social inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d82f6e58968294b33a470119404337f4
Autor:
Ac, R
This dissertation looks at the problem of increasing rates of antisocial behaviour in western countries. As such, the structural models being proposed to ameliorate this trend in Australia are questioned. Current strategies include tough punitive mea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b51115f107e1d026f60521ef2185e981
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S225-S226 (2024)
Introdução: O linfoma tipo Mucosa Associated Lymphoid Tissue (MALT) é uma neoplasia primária do tipo não-Hodgkin derivada do tecido linfoide presente na mucosa e não relacionado aos linfonodos. Cerca de 50% dos casos desse tipo de neoplasia oco
Externí odkaz:
https://doaj.org/article/5c30865d280d4691819ce46d9d1cb324
Autor:
GS Correa, SZ Jorge, HC Silva, AC Ramalho, MBC Silveira, LFT Ribeiro, MEJ Marinho, RVP Souza, PHSCD Santos, G Suhett
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S314-S315 (2024)
Introdução: A terapia CAR-T usa células T do próprio paciente modificadas geneticamente para combater o câncer. Estudos mostram que a CAR-T direcionada ao CD19 é eficaz contra leucemias, especialmente a leucemia linfoblástica aguda recidivante
Externí odkaz:
https://doaj.org/article/578323de02824724957664d18920acbe
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S1018- (2024)
Introdução: A Anemia Aplásica (AA) é uma doença rara, sem predominância degênero, com maior incidência na infância e após os 60 anos, especialmente napopulação asiática. A AA pode ser classificada pelo grau de acometimento(Moderada, Seve
Externí odkaz:
https://doaj.org/article/4a073ffec4cb498d917fb1a239350696
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S1017- (2024)
Introduction: Allogeneic Stem Cell Transplant (ASCT) is a curative strategy for varioushematological diseases. Following ASCT, chimerism analysis becomes instrumental inassessing engraftment success, guiding immunosuppression strategies, anddetermini
Externí odkaz:
https://doaj.org/article/621329a292d1458e8b95ebf406e04680
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S697- (2023)
Estima-se que apenas 1,8% da população brasileira tenha o hábito de doar sangue, o que frequentemente acarreta a redução dos estoques de hemocomponentes para níveis críticos e requer sucessivas campanhas para manter um fluxo contínuo de doaç
Externí odkaz:
https://doaj.org/article/26fdd16f93914e35bf38964c33a055c3
Autor:
Sanne A E Peters, Mark Woodward, Fw Asselbergs, Folkert W Asselbergs, B Williams, GP McCann, R Zaal, Carinna Hockham, P Dark, S Prasad, A Aujayeb, A Mosterd, M Saxena, L Gabriel, CE Delsing, J De Sutter, R Pisters, P van der Meer, M Caputo, A Schut, P van der Harst, MT Kearney, YM Pinto, DP Ripley, RG Tieleman, J Redón, A Moriarty, P Woudstra, Marijke Linschoten, G Captur, Chahinda Ghossein, AK Al-Ali, FA Al-Muhanna, NYY Al-Windy, YA Almubarak, AN Alnafie, M Alshahrani, AM Alshehri, RL Anthonio, JM ten Berg, AJM van Boxem, N Charlotte, HGR Dorman, JT Drost, ME Emans, JB Ferreira, WH van Gilst, BE Groenemeijer, HE Haerkens-Arends, B Hedayat, DJ van der Heijden, E Hellou, RS Hermanides, JF Hermans-van Ast, MWJ van Hessen, SRB Heymans, ICC van der Horst, SH van Ierssel, LS Jewbali, HAM van Kesteren, Kietselaer BLJH, AMH Koning, PY Kopylov, AFM Kuijper, JM Kwakkel-vanErp, van der Linden MMJM, M Linschoten, GCM Linssen, Macias Ruiz R, FJH Magdelijns, Martens FMAC, MFL Meijs, P Messiaen, PS Monraats, L Montagna, PR Nierop, CEE van Ofwegen-Hanekamp, H Poorhosseini, AC Reidinga, MIA Ribeiro, R Salah, E Saneei, J Schaap, Schellings DAAM, A Shafiee, AC Shore, HJ Siebelink, M van Smeden, PC Smits, E Tessitore, P Timmermans, RA Tio, FVY Tjong, CA den Uil, EM Van Craenenbroeck, van Veen HPAA, T Veneman, DO Verschure, JK de Vries, RMA van de Wal, DJ van de Watering, ICD Westendorp, PHM Westendorp, C Weytjens, E Wierda, KW Wu, AG Zaman, PM van derZee
Publikováno v:
BMJ Medicine, Vol 2, Iss 1 (2023)
Objective To assess whether the risk of cardiovascular complications of covid-19 differ between the sexes and to determine whether any sex differences in risk are reduced in individuals with pre-existing cardiovascular disease.Design Registry based o
Externí odkaz:
https://doaj.org/article/b7d0598755264004ab8a236f850ae4a9